Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
A1GI34.SA
Strong BuyAgilent Technologies, Inc. · Healthcare · United States · $39.1B · Avg Vol: $2K/d
87
StockRankGet insider-trade alerts
Q
69
V
43
M
73
P/E (TTM)
27.6x
ROE
21.0%
D/E
0.5x
Dividend %
0.5%
COMPANY DESCRIPTION
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.7B | 35.6B | 33.9B | 36.2B | 0.5% | 38.4B | 39.0B | 41.5B | 7.1% |
| EPS (BRL) | 0.23 | 0.23 | 0.23 | 0.24 | 1.7% | — | — | — | — |
| Shares | 2.8B | 2.8B | 2.8B | 2.8B | 0.0% | 2.8B | — | — | — |
| Debt | 14.4B | 14.2B | 17.6B | 17.5B | 6.6% | 20.6B | — | — | — |
| Equity | 27.6B | 30.4B | 30.7B | 35.1B | 8.3% | — | — | — | — |
| Op CF | 6.8B | 9.2B | 9.1B | 8.1B | 5.9% | 8.4B | — | — | — |
| Inv CF | -1.8B | -1.6B | -6.5B | -2.1B | — | — | — | — | — |
| Fin CF | -7.1B | -4.8B | -3.9B | -3.7B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+5.1%
SMA 50SMA 200
Close
$13.88
52W High
$15.72
From 52W High
0.9%
SCORE BREAKDOWN
Quality
69
ROIC
16.2%86.9
ROE
21.0%89.0
GP/Assets
31.2%67.3
Op. Margin
23.6%85.9
FCF/Assets
8.5%81.6
Piotroski
550.0
Int. Cover
16.0x69.0
D/E Ratio
0.54x29.0
Current Ratio
2.05x39.4
Value
43
P/E (TTM)
27.6x43.1
EV/EBITDA
18.8x35.1
P/FCF
36.0x36.9
P/B
1.0x83.5
P/S
5.3x41.5
Div Yield
0.5%12.0
Momentum
73
52W High %
88%79.6
RS 6M
29%84.6
SMA 50/200
1.03x66.0
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
8%46.9
FUNDAMENTALS
Market Cap
$39.1B
P/E (Forward)
—
Gross Margin
53.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of A1GI34.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| A1GI34.SA | Agilent Technologies, Inc.(you) | $39.1B | 87 | Strong Buy |
| ILU.DE | Illumina, Inc. | $33.3B | 88 | Strong Buy |
| LH | Labcorp Holdings Inc. | $27.2B | 86 | Strong Buy |
| DGX | Quest Diagnostics Incorporated | $26.8B | 85 | Strong Buy |
| IQV | IQVIA Holdings Inc. | $43.1B | 78 | Buy |
| IDXX.MX | IDEXX Laboratories, Inc. | $43.9B | 73 | Buy |
| MEDP | Medpace Holdings, Inc. | $16.8B | 84 | Strong Buy |
| WAT | Waters Corporation | $40.7B | 63 | Hold |
| NTRA | Natera, Inc. | $47.0B | 56 | Hold |
| DHER34.SA | Danaher Corporation | $151.9B | 76 | Buy |
Peer medians: ROE -25.0% · P/E 31.0x · Gross margin 58.8%